{"nct_id":"NCT06024239","title":"A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2023-08-31","start_date_type":"ACTUAL","primary_completion_date":"2025-03-04","primary_completion_date_type":"ACTUAL","completion_date":"2025-03-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}